Inactive Instrument

Other languages Biovica International AB (publ) Nasdaq Stockholm

Equities

SE0008613731

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Biovica International AB Announces Divitum® Tka in Observational Trial	Apr. 12
Biovica International AB Announces Appointments to the Nomination Committee	Apr. 11
Biovica International AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 14
Biovica Announces Interventional DiviTum TKa Trial Launches at Washington University	Mar. 13
Biovica International Signs SEK 1.2 Million Master Service Agreement	Mar. 12
Biovica Signs Master Service Agreement for Tka Testing with Leading Pharma Company	Mar. 07
Biovica Partners with Palex Group to Launch Breast Cancer Treatment Response Kits; Stock Surges	Jan. 19
Biovica International Signs Agreement with Palex Group	Jan. 19
Biovica Receives License for Maryland State	Dec. 01
Biovica International AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Nov. 28
Biovica Receives Final Pricing Decision for DiviTum TKa Test by Medicare	Nov. 21
Biovica Signs Commercial Partner Agreement for the Divitum(R) Tka Assay in the Nordics with Axlab	Nov. 13
Biovica International AB Signs Agreement for DivTum(R) TKa with World Re-Known Cancer Clinic	23-10-12
Biovica Signs Second Agreement with US Healthcare Provider	23-09-25
Biovica Signs US Agreement with Leading Healthcare Provider in Arizona	23-09-19
Biovica International AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-06
Biovica Announces the Start of a DiviTum(R) TKa Clinical Trial	23-08-24
Biovica Signs US Commercial Agreement with Occum Health	23-07-31
Biovica International Achieves PLA code for Medicare	23-07-21
Biovica International AB Reports Earnings Results for the Full Year Ended April 30, 2023	23-06-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biovica International AB (publ) Nasdaq Stockholm

Equities

SE0008613731

Other languages

Filters